Clinical Trials
8 trialsNCT00880074 2023-06-26
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00813566 2022-04-27
Multi-Tracer PET Assessment of Primary Brain Tumors
University of Utah
Phase 1 Completed
NCT02146222 2019-11-18
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT01480050 2019-05-22
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00575393 2018-10-09
Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
Mayo Clinic
Phase 1 Completed
NCT00499135 2017-10-10
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01243359 2014-04-02
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
National Cancer Institute (NCI)
Phase 1 Completed
NCT00553748 2008-07-03
Phase I, Open Label, Single Center Safety Study of [F-18]FLT
Siemens Molecular Imaging
Phase 1 Completed